Tissue Sealants and Tissue Adhesive Market

Tissue Sealants and Tissue Adhesive Market Size, Market Forecast and Outlook By FMI

The tissue sealants and tissue adhesive market was valued at USD 2.1 billion in 2025. The market is set to reach USD 2.2 billion by 2026-end and grow at a CAGR of 8.4% between 2026–2036 to reach USD 5.0 billion by 2036. Gelatin based sealants will dominate with a 62.2% share, while Cardiovascular surgery will lead with a 28.6%% share.

Summary of the Tissue Sealants and Tissue Adhesive Market

• Demand and Growth Drivers
  • Growing surgical procedure volumes across cardiovascular, orthopedic, and general surgery are creating sustained demand for tissue sealants that improve hemostasis and reduce operative time.
  • The shift toward minimally invasive surgical techniques is driving adoption of tissue sealants and adhesives that provide reliable tissue bonding without mechanical closure devices.
  • Increasing ambulatory surgical center utilization and outpatient procedure growth are expanding demand for tissue adhesives that enable rapid wound closure and faster patient discharge.
• Product and Segment View
  • Gelatin based sealants are expected to account for 62.2% of the product type segment in 2026, reflecting their established clinical safety record, hemostatic efficacy, and broad surgical application.
  • Cardiovascular surgery is expected to represent 28.6% of the application segment in 2026, driven by high surgical volumes and the critical need for effective hemostasis during cardiac and vascular procedures.
  • Collagen based sealants are growing as alternatives for wound closure and tissue bonding in orthopedic and reconstructive surgery applications.
• Geography and Competitive Outlook
  • China is expected to lead growth at 8.5%, reflecting its expanding surgical volume, healthcare infrastructure development, and growing adoption of advanced surgical consumables.
  • European markets including Spain (4.5%), Italy (4.1%), and France (3.3%) reflect established surgical practice and growing adoption of tissue sealants in ambulatory and minimally invasive settings.
  • Companies combining clinical evidence, surgical specialty coverage, and regulatory approval across multiple markets are positioned to capture procurement during the forecast period.
• Analyst Opinion
  • The tissue sealants and tissue adhesive market is shaped by surgical procedure volume growth and the clinical value of products that improve hemostasis, reduce operative time, and support minimally invasive techniques.
  • Adoption is driven by evidence that tissue sealants reduce blood loss, decrease reoperation rates, and shorten hospital stays compared to conventional surgical closure methods in appropriate applications.
  • Growth at 8.4% CAGR reflects expanding surgical volumes, growing clinical acceptance, and the shift toward ambulatory and minimally invasive procedures that favor adhesive and sealant closure.
  • Companies investing in next generation sealant formulations with faster polymerization, improved biocompatibility, and expanded indication coverage are positioned to capture growing surgical demand.

Key Takeaways, Market Size, and Forecast

• The tissue sealants and tissue adhesive market was valued at USD 2.06 billion in 2025.
• By 2036, the Tissue Sealants and Tissue Adhesive Market is expected to be worth USD 5 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 8.4%.
• The market is projected to create an incremental opportunity of USD 2.77 billion between 2026 and 2036.
• In 2026, gelatin based sealants is expected to account for 62.2% of the product type segment, driven by gelatin's established clinical safety profile, superior hemostatic capability, and broad surgical application across cardiovascular, orthopedic, and general surgical procedures.
• China (8.5%) and Spain (4.5%) are two of the fastest growing markets in the world.

Tissue Sealants and Tissue Adhesive Market Definition

The tissue sealants and tissue adhesive market covers biological and synthetic products used to achieve hemostasis, seal tissue, close wounds, and bond tissue surfaces during surgical procedures. Products include gelatin based sealants, collagen based sealants, fibrin sealants, and cyanoacrylate adhesives used in cardiovascular surgery, burns and skin grafting, cosmetic procedures, and reconstructive surgery across hospitals, specialty clinics, and ambulatory surgical centers.

Tissue Sealants and Tissue Adhesive Market Inclusions

Market scope includes all commercially traded tissue sealant and adhesive products categorized by product type (gelatin based sealants, collagen based sealants), application (cardiovascular surgery, burns and skin grafting, cosmetic, reconstructive), and end user (hospitals, specialty clinics, ambulatory surgical centers). Revenue coverage spans 2026 to 2036.

Tissue Sealants and Tissue Adhesive Market Exclusions

The scope does not include general purpose medical adhesive tapes, wound dressing products without sealant properties, bone cement products, or dental adhesive materials.

Tissue Sealants and Tissue Adhesive Market Research Methodology

• Primary Research: FMI analysts conducted interviews with manufacturers, technology specialists, and procurement professionals across key markets.
• Desk Research: Combined data from industry associations, regulatory bodies, and manufacturer disclosures.
• Market Sizing and Forecasting: Bottom up methodology aggregating segment and regional data with adoption velocity projections.
• Data Validation: Cross checked quarterly against production data, trade statistics, and manufacturer reporting.

Why is the Tissue Sealants and Tissue Adhesive Market Growing?

• Growing global surgical procedure volumes in cardiovascular, orthopedic, and general surgery create proportional demand for tissue sealants that improve intraoperative hemostasis and wound management.
• Minimally invasive surgery adoption drives demand for tissue adhesives that provide reliable tissue closure through small access incisions where traditional suturing is impractical.
• Clinical evidence supporting reduced blood loss, lower reoperation rates, and shorter hospital stays with tissue sealants is expanding surgeon adoption across surgical specialties.

Demand for tissue sealants and adhesives is driven by surgical procedure volume growth and the clinical advantages these products provide over conventional closure methods. Tissue sealants achieve hemostasis at surgical sites where sutures and staples are insufficient, reducing blood loss and operative time. Tissue adhesives provide wound closure without suture removal, improving patient comfort and enabling faster discharge from ambulatory surgical settings.

Cardiovascular surgery represents the highest value application due to the critical importance of reliable hemostasis during cardiac and vascular procedures. Gelatin based and fibrin sealants are used routinely to control bleeding at suture lines, anastomoses, and cannulation sites. The aging global population and growing cardiovascular disease prevalence drive increasing surgical volumes that create proportional sealant demand.

The ambulatory surgery trend is expanding the addressable market for tissue adhesives. Outpatient procedures require wound closure methods that support rapid recovery and patient self-care. Cyanoacrylate tissue adhesives and advanced collagen based sealants provide closure that does not require follow-up suture removal, aligning with ambulatory surgical center workflow and discharge requirements.

Market Segmentation Analysis

• Gelatin based sealants represent 62.2% of the segment, reflecting their established safety profile and broad application across cardiovascular, orthopedic, and general surgical procedures.
• Cardiovascular surgery accounts for 28.6% of the application segment, driven by the critical need for effective hemostasis during cardiac and vascular operations.
• Ambulatory surgical centers are the fastest growing end user channel as outpatient procedure growth drives demand for rapid wound closure solutions.

The tissue sealants and adhesive market segments by product type, application, and end user. By product type, the market covers gelatin based and collagen based sealants. By application, the market addresses cardiovascular surgery, burns and skin grafting, cosmetic, and reconstructive procedures.

Insights into the Gelatin Based Sealants Product Type Segment

In 2026, gelatin based sealants are expected to account for 62.2% of the product type segment. Their dominance reflects decades of clinical use that has established a comprehensive safety and efficacy evidence base across surgical specialties. Gelatin sealants provide effective hemostasis through a combination of mechanical matrix support and coagulation cascade activation at surgical bleeding sites.

Insights into the Cardiovascular Surgery Application Segment

Cardiovascular surgery is expected to represent 28.6% of the application segment in 2026. Cardiac and vascular surgical procedures require reliable hemostasis at high pressure vascular sites where mechanical closure alone may not achieve adequate sealing. Gelatin based and fibrin sealants are used routinely to supplement suture closure at anastomoses, graft sites, and cannulation points.

Tissue Sealants and Tissue Adhesive Market Drivers, Restraints, and Opportunities

• Surgical volume growth and clinical evidence supporting sealant benefits create sustained demand across cardiovascular, orthopedic, and general surgical specialties.
• High product costs and reimbursement variability across healthcare systems constrain adoption in price sensitive markets and routine procedures.
• Minimally invasive surgery and ambulatory care expansion create growing demand for tissue adhesives that support rapid closure and patient discharge.

The tissue sealants market is expanding at 8.4% CAGR driven by surgical volume growth, clinical acceptance, and ambulatory surgery expansion. Cost and reimbursement constraints limit adoption in some settings, while minimally invasive trends provide premium growth.

Surgical Volume Growth

Growing cardiovascular, orthopedic, and general surgical procedure volumes create proportional demand for tissue sealants. Aging populations and chronic disease prevalence drive increasing surgical activity worldwide.

Cost and Reimbursement Constraints

Tissue sealants carry significant per-unit costs that affect adoption in price sensitive healthcare systems. Variable reimbursement coverage across markets constrains usage to procedures where clinical benefits clearly justify costs.

Minimally Invasive Surgery Expansion

Growing adoption of minimally invasive techniques creates demand for tissue adhesives that provide reliable closure through small access approaches where conventional suturing is technically challenging.

Next Generation Formulation Development

Investment in faster polymerizing, stronger bonding, and more biocompatible sealant formulations creates product differentiation and expands addressable surgical applications.

Analysis of Tissue Sealants and Tissue Adhesive Market By Key Countries

Country	CAGR
China	8.5%
Spain	4.5%
Italy	4.1%
Canada	3.8%
France	3.3%
UK	2.7%
Germany	2.3%
USA	2.2%

• China leads at 8.5% CAGR through 2036.
• Spain leads at 4.5% CAGR through 2036.
• Italy leads at 4.1% CAGR through 2036.
• Canada leads at 3.8% CAGR through 2036.

The global tissue sealants and tissue adhesive market is projected to grow at a CAGR of 8.4% from 2026 to 2036. The analysis covers more than 30 countries, with the leading markets detailed below.

Demand Outlook for Tissue Sealants and Tissue Adhesive Market in China

China is expected to lead growth at 8.5% through 2036, reflecting expanding surgical volumes, healthcare modernization, and growing adoption of advanced surgical consumables.

• Expanding surgical volumes create proportional sealant demand.
• Healthcare modernization drives adoption of advanced surgical products.
• Hospital investment supports procurement of premium consumables.

Future Outlook for Tissue Sealants and Tissue Adhesive Market in Spain

Spain is expected to grow at 4.5% through 2036, reflecting its surgical practice, growing ambulatory surgery adoption, and increasing use of tissue sealants across specialties.

• Surgical practice supports established sealant demand.
• Ambulatory surgery growth creates tissue adhesive opportunity.
• Specialty adoption broadens sealant usage across procedures.

Opportunity Analysis of Tissue Sealants and Tissue Adhesive Market in Italy

Italy is expected to grow at 4.1% through 2036, driven by its advanced healthcare system, cardiac surgery volumes, and growing minimally invasive procedure adoption.

• Advanced healthcare system supports tissue sealant procurement.
• Cardiac surgery volumes drive cardiovascular sealant demand.
• Minimally invasive adoption creates tissue adhesive growth.

In-depth Analysis of Tissue Sealants and Tissue Adhesive Market in Canada

Canada is expected to grow at 3.8% through 2036, reflecting surgical volume growth, ambulatory care expansion, and growing clinical adoption of tissue sealant products.

• Surgical volume growth supports proportional sealant demand.
• Ambulatory care expansion creates tissue adhesive opportunity.
• Clinical adoption growth broadens sealant usage.

Sales Analysis of Tissue Sealants and Tissue Adhesive Market in the United States

The USA is expected to grow at 2.2% through 2036, reflecting a mature market with established sealant usage and incremental growth from ambulatory settings and new indications.

• Mature market supports established surgical sealant demand.
• Ambulatory setting expansion creates incremental adhesive growth.
• New indication approvals expand addressable procedure base.

Competitive Landscape and Strategic Positioning

• Baxter International Inc. leads the market with comprehensive product and service capabilities and established customer relationships.
• Multiple global and regional players compete on technology capability, certification credentials, and geographic reach.
• Emerging players are targeting specialized applications and next generation technology development.

Baxter International leads the global market with its comprehensive surgical sealant portfolio including gelatin based, fibrin, and synthetic sealant products used across cardiovascular, orthopedic, and general surgery. Johnson & Johnson provides tissue adhesive and wound closure solutions through its Ethicon surgical division.

Smith & Nephew and C.R Bard serve the global surgical market with wound management and tissue bonding products. Exapharma provides specialty tissue sealants for European surgical markets.

Integra LifeSciences focuses on collagen based tissue products for reconstructive and wound care applications. Emerging players including Cohesion Biomedical, Tissuemed, and Adhezion Biomedical are developing next generation adhesive and sealant formulations.

Key Companies in the Tissue Sealants and Tissue Adhesive Market

Key global companies leading the tissue sealants and tissue adhesive market include:

• Baxter International Inc. (USA), Johnson & Johnson (USA), Exapharma (France), Smith & Nephew (UK), C.R Bard (USA) hold strong positions through manufacturing scale, certification credentials, and established customer relationships.
• Integra LifeSciences (USA), Cohesion Biomedical (USA), Tissuemed (UK), Adhezion Biomedical (USA) are expanding presence through regional focus and specialized product development.

Competitive Benchmarking: Tissue Sealants and Tissue Adhesive Market

Company	Product Portfolio	Clinical Evidence	Surgical Coverage	Geographic Reach
Baxter International	High	High	Strong	Global
Johnson & Johnson	High	High	Strong	Global
Smith & Nephew	High	High	Strong	Global
C.R Bard	High	High	Strong	Global
Exapharma	Medium	High	Moderate	Europe
Integra LifeSciences	High	High	Strong	North America, Global
Cohesion Biomedical	Medium	Medium	Moderate	North America
Tissuemed	Medium	High	Moderate	Europe
Adhezion Biomedical	Medium	Medium	Moderate	North America

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Tissue Sealants and Tissue Adhesive Market

Major Global Players

• Baxter International Inc. (USA)
• Johnson & Johnson (USA)
• Exapharma (France)
• Smith & Nephew (UK)
• C.R Bard (USA)

Emerging Players/Startups

• Integra LifeSciences (USA)
• Cohesion Biomedical (USA)
• Tissuemed (UK)
• Adhezion Biomedical (USA)

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD Billion 2.23 to USD Billion 5, at a CAGR of 8.4%
Market Definition	The tissue sealants and tissue adhesive market covers biological and synthetic products used to achieve hemostasis, seal tissue, close wounds, and bond tissue surfaces during surgical procedures. Products include gelatin based sealants, collagen based sealants, fibrin sealants, and cyanoacrylate adhesives used in cardiovascular surgery, burns and skin grafting, cosmetic procedures, and reconstructive surgery across hospitals, specialty clinics, and ambulatory surgical centers.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	China, Spain, Italy, Canada, France, UK, Germany, USA, and 30 plus countries
Key Companies Profiled	Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard, Integra LifeSciences, Cohesion Biomedical, Tissuemed
Forecast Period	2026 to 2036
Approach	Hybrid bottom up and top down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Tissue Sealants and Tissue Adhesive Market Segmented by Product Type:

• Gelatin based sealants
• Collagen based sealants

Tissue Sealants and Tissue Adhesive Market Segmented by Application:

• Cardiovascular surgery
• Burns & skin grafting
• Cosmetic
• Reconstructive

Tissue Sealants and Tissue Adhesive Market Segmented by End User:

• Hospitals
• Specialty clinics
• Ambulatory surgical centers

Tissue Sealants and Tissue Adhesive Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. USA Food and Drug Administration. (2025). FDA Guidance on Tissue Sealants and Hemostatic Agents: Premarket Requirements. FDA.
• 2. European Medicines Agency. (2024). EMA Guidelines on Biological Tissue Sealants and Surgical Adhesives. EMA.
• 3. American College of Surgeons. (2025). ACS Clinical Practice Guidelines: Use of Tissue Sealants in Surgical Practice. ACS.
• 4. World Health Organization. (2024). WHO Global Guidelines on Surgical Safety and Hemostasis Management. WHO.
• 5. International Society on Thrombosis and Haemostasis. (2025). ISTH Recommendations on Surgical Sealant Applications. ISTH.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list.

This Report Answers

• Estimating the size of the market and projected revenue from 2026 to 2036.
• Segmentation by product type, application, end user, and region.
• Insights across more than 30 country markets.
• Analysis of sealant formulation technology and clinical evidence trends.
• Assessment of the competitive landscape and manufacturer positioning.
• Identification of investment opportunities in cardiovascular, minimally invasive, and ambulatory surgical applications.
• Tracking regulatory developments in surgical sealant approval requirements.
• Delivery of data in PDF and Excel formats.